慢性手部湿疹:EADV接触性皮炎工作组常见问题与实用建议
该综述以问答形式覆盖慢性手部湿疹(CHE)的病因流行病学、临床表现、鉴别诊断、病程评分、生活质量影响及防治。CHE可由刺激性或变应性接触性皮炎、特应性皮炎等引起,常与职业暴露相关,影响生活质量并带来社会经济负担,治疗包括外用与系统药物,生物制剂和JAK抑制剂在中重度病例中显示前景但安全性和疗效仍在研究中。
要点
- CHE可由刺激性接触性皮炎、变应性接触性皮炎、特应性皮炎或其他未分类原因引起,常与职业暴露相关。
- CHE临床表现多样,具有不同临床和病因亚型,有助于诊断和治疗。
- 预防重在避免触发因素和正确手部护理,治疗包括外用糖皮质激素、钙调神经磷酸酶抑制剂及系统治疗。
核心结论
- CHE是一种常见且复杂的皮肤病,显著影响患者生活质量和社会职业功能。
- 当前治疗以控制症状为主,亟需进一步研究CHE发病机制以开发更靶向有效的长期疗法。
研究设计与样本
- 本综述采用问答形式,由EADV接触性皮炎工作组撰写,覆盖CHE的主要议题。
主要发现
- CHE可能由刺激性接触性皮炎、变应性接触性皮炎、特应性皮炎或其他未分类原因引起,常与职业暴露相关,尤其在频繁接触水的环境中。
- CHE在女性中发病率更高,但男性往往更严重;遗传易感性起作用,但环境因素特别是职业环境是关键贡献者。
- CHE的发病机制涉及不同但总体相似的免疫反应,包括Th1、Th2和先天免疫系统反应,以及慢性皮肤屏障功能障碍。
- CHE对生活质量的影响与其他慢性疾病相当,带来显著心理社会和经济后果,包括缺勤和医疗费用增加。
- 生物制剂包括JAK抑制剂在开发中显示对中重度病例的前景,但其安全性和疗效仍在研究中。
临床怎么用
- 预防策略应聚焦于避免触发因素和促进正确的手部护理。
- 治疗包括外用和系统治疗的组合,非药物措施如保湿剂、外用糖皮质激素和钙调神经磷酸酶抑制剂是常见治疗。
局限性
- CHE的流行病学可能被广泛低估。
- 生物制剂包括JAK抑制剂的安全性和疗效仍在研究中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic hand eczema (CHE) is a prevalent and complex skin condition that can significantly affect patients' quality of life (QoL) and social and occupational functioning. In this review structured as questions and answers format, we aimed to target the main topics of CHE including etiopathogenetic-epidemiologic background, clinical findings, differential diagnosis/diagnostic assessment, course-prognosis and scoring, impact on QoL and psycho-socio-economic status, prevention and treatment. CHE may result from irritant contact dermatitis (ICD), allergic contact dermatitis (ACD), atopic dermatitis (AD) or other unclassified causes and is often related to occupational exposure, especially in environments with frequent water exposure. CHE can manifest in various forms, with distinct clinical and aetiological subtypes, which helps both in diagnosis and treatment. The epidemiology of CHE is probably widely underreported, but it has a higher incidence in women, though it tends to be more severe in men. Genetic predisposition plays a role, but environmental factors, particularly in occupational settings, are key contributors. Pathogenetically, CHE involves different but overall similar immune responses depending on the subtype, including both Th1, Th2 and innate immune system reactions, alongside to chronic skin barrier dysfunction. The impact of CHE on QoL is comparable to other chronic conditions, with significant psycho-social and economic consequences, including work absenteeism and increased healthcare costs. Preventive strategies focus on avoiding trigger factors and promoting proper hand care, while treatment involves a combination of topical and systemic therapies. Non-pharmacological measures like moisturizers, topical corticosteroids and calcineurin inhibitors are common treatments. Recent advances in the development of biologics, including JAK inhibitors, show promise for moderate to severe cases, although their safety and efficacy remain under investigation. While current treatments aim to manage symptoms, there is an urgent need for further research into the pathogenesis of CHE to enable the development of more targeted and effective long-term therapies.
引用
- Balato A, Tancredi V, Aerts O, et al. Chronic hand eczema: Common questions and practical recommendations from the EADV Contact Dermatitis Task Force. J Eur Acad Dermatol Venereol. 2025. PMID: 41020637. doi:10.1111/jdv.70068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。